Psych Congress Action Center

Welcome to the Psych Congress Action Center, designed to bring you the latest updates from the annual Psych Congress meeting. This collection features the latest scientific advances, groundbreaking research presentations, and expert insights on psychopharmacology, prevalent mental health conditions, and more.

LikeLikedUnlike

Episodes 1-15 of 16

Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study
Psychiatry and Mental Health
Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study
- Christoph U. Correll, MD
  Peer
Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4
Psychiatry and Mental Health
Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4
- Jonathan M. Meyer, MD
  Peer
Supporting the Peripartum Period Through Perinatal Psychiatry
NeuroFrontiers
Supporting the Peripartum Period Through Perinatal Psychiatry
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Nichelle Haynes, DO
  Peer
Highlights from the 2023 Psych Congress
NeuroFrontiers
Highlights from the 2023 Psych Congress
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Craig Chepke, MD, FAPA
  Peer
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
NeuroFrontiers
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
Locked Up in My Own Mind: Challenges in the Criminal Justice System
Psych Congress Action Center
Locked Up in My Own Mind: Challenges in the Criminal Justice System
advertisement
Clarity for Schizophrenia: The Latest in Drug Treatment
Psych Congress Action Center
Clarity for Schizophrenia: The Latest in Drug Treatment
New Drug Approved for PPD: Solving an Unmet Need
NeuroFrontiers
New Drug Approved for PPD: Solving an Unmet Need
Me2/ & Classical Music in Mental Health: Expert Insights from the Psych Congress
Psych Congress Action Center
Me2/ & Classical Music in Mental Health: Expert Insights from the Psych Congress
Uncovering the State of Antidepressants: Updates from Psych Congress
Psych Congress Action Center
Uncovering the State of Antidepressants: Updates from Psych Congress
Psych Congress 2022: A Look at New Mechanisms of Action in Schizophrenia
Psych Congress Action Center
Psych Congress 2022: A Look at New Mechanisms of Action in Schizophrenia
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Craig Chepke, MD, FAPA
  Peer
Exploring Marijuana Use in Psychopharmacology: A Look Ahead at the Psych Congress
Psych Congress Action Center
Exploring Marijuana Use in Psychopharmacology: A Look Ahead at the Psych Congress
advertisement
Exploring Anticipated Highlights & Updates from Psych Congress 2022
Psych Congress Action Center
Exploring Anticipated Highlights & Updates from Psych Congress 2022
A Look at LAI Antipsychotics for Bipolar I Disorder: A Preview of the Psych Congress
Psych Congress Action Center
A Look at LAI Antipsychotics for Bipolar I Disorder: A Preview of the Psych Congress
Highlights from the Psych Congress: Uncovering Updates from the DSM-5-TR
Psych Congress Action Center
Highlights from the Psych Congress: Uncovering Updates from the DSM-5-TR